CHICAGO, IL – New research presented at ENDO 2026, the Endocrine Society’s annual meeting, reveals a concerning link between early developmental exposure to a widely used plastic chemical and heightened anxiety levels in adult male rats. The study, conducted by researchers at the University of Buenos Aires School of Medicine, suggests that prenatal and early postnatal exposure to di-(2-ethylhexyl) phthalate (DEHP), a common plasticizer, can induce long-lasting behavioral changes with potential implications for human health.
Understanding the Chemical and its Pervasiveness
DEHP is a phthalate ester, a class of chemicals extensively used to increase the flexibility, transparency, durability, and longevity of plastics. Its widespread application means it is incorporated into a vast array of consumer products, making it a ubiquitous environmental contaminant. These products include, but are not limited to, flexible polyvinyl chloride (PVC) plastics found in medical devices such as IV tubing and blood bags, children’s toys, shower curtains, flooring, wire and cable insulation, and various packaging materials. The very properties that make DEHP desirable for manufacturers also contribute to its ability to leach out of products over time, leading to human exposure through ingestion, inhalation, and dermal contact.
The concern surrounding phthalates, including DEHP, stems from their classification as endocrine-disrupting chemicals (EDCs). EDCs are exogenous substances or mixtures that alter function(s) of the endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, or (sub)populations. The endocrine system, a complex network of glands and hormones, plays a critical role in regulating a vast array of physiological processes, including growth, metabolism, reproduction, and importantly, behavior and neurodevelopment. EDCs can mimic, block, or interfere with the body’s natural hormones, leading to developmental, reproductive, neurological, and immune system problems.
Previous scientific investigations have already established DEHP’s capacity to disrupt various organ systems in both animal models and human populations. Notably, its effects on the reproductive and nervous systems have been a significant area of focus. This new research builds upon this existing body of knowledge by specifically examining the impact of early-life DEHP exposure on anxiety-related behaviors in adulthood, and crucially, exploring the potential neurochemical mechanisms underlying these changes.
Investigating the Neuroendocrine Pathways
The research team, led by Osvaldo Juan Ponzo, M.D., Ph.D., a professor of physiology at the University of Buenos Aires School of Medicine, hypothesized that DEHP exposure during critical developmental windows could induce enduring behavioral modifications. Their investigation delved into the potential involvement of two key neurochemical agents: gamma-aminobutyric acid (GABA) and testosterone.
GABA is the principal inhibitory neurotransmitter in the mammalian central nervous system. It plays a crucial role in reducing neuronal excitability throughout the nervous system. By inhibiting nerve transmission, GABA produces a calming effect, and its dysregulation has been implicated in various neurological and psychiatric disorders, including anxiety.
Testosterone, the primary male sex hormone, is not only vital for reproductive development and function but also exerts significant influences on brain development and behavior. It has been shown to affect mood, cognition, and social behaviors, and its levels can be modulated by various environmental factors.
The study aimed to determine if early DEHP exposure altered anxiety behaviors and if the observed effects could be mitigated by interventions targeting GABAergic signaling or testosterone levels. This dual approach allowed researchers to not only establish a causal link between early DEHP exposure and adult anxiety but also to elucidate potential therapeutic avenues.
Experimental Design and Timeline
The study employed a controlled experimental design using Sprague-Dawley rats, a commonly used animal model in biomedical research. The experimental timeline was meticulously planned to encompass critical developmental periods.
Timeline of the Study:
- Pregnancy Initiation: Pregnant female rats were sourced and housed under standard laboratory conditions.
- DEHP Exposure Begins (Gestational Day 1): Beginning on the first day of pregnancy, the experimental group of female rats received daily oral doses of DEHP. This dosage was carefully selected to reflect potential human exposure levels.
- Continued Exposure (Through Lactation): The daily oral administration of DEHP continued throughout the gestation period and extended until the pups were weaned. This ensured exposure during both the prenatal (in utero) and immediate postnatal (early nursing) developmental stages, periods known for their heightened sensitivity to environmental influences on neurodevelopment.
- Pups Raised to Adulthood: Following weaning, the male offspring were raised under standard conditions, free from further DEHP exposure.
- Adult Anxiety Assessment (Postnatal Day 70): Upon reaching sexual maturity and adulthood, at approximately 70 days of age, the male rats underwent behavioral testing to assess their anxiety-related behaviors. This age is considered equivalent to late adolescence or early adulthood in humans.
- Intervention and Testing (Pre-EPM): In a subset of the adult male rats, interventions were administered shortly before the anxiety assessment. Some rats received GABA agonists, while others were treated with testosterone.
This phased approach allowed researchers to isolate the effects of early-life exposure from any potential ongoing exposure in adulthood, and to investigate the reversibility of these effects.
Assessing Anxiety: The Elevated Plus Maze
To quantify anxiety-related behaviors, the researchers utilized the elevated plus maze (EPM), a well-established and validated behavioral paradigm in rodent research. The EPM is designed to exploit the innate conflict in rodents between their tendency to explore novel environments and their aversion to open, elevated spaces, which are perceived as risky.
The maze consists of a central platform from which four arms extend. Two of these arms are enclosed by high walls (closed arms), offering a sense of security. The other two arms are open and lack any walls (open arms), exposing the animal to height and a lack of cover.
During the EPM test, each rat was placed in the central platform and allowed to explore freely for a set period, typically 5-10 minutes. The researchers meticulously recorded several key behavioral parameters:
- Arm Entry Frequency: The number of times a rat entered each type of arm (open versus closed).
- Time Spent in Each Arm: The duration the rat spent exploring the open arms and the closed arms.
- Freezing Time: The amount of time the rat remained immobile. Freezing is a common behavioral indicator of fear and anxiety in rodents, representing a state of vigilance and immobility in response to perceived threats.
Rats exhibiting higher levels of anxiety are expected to spend more time in the protective closed arms, make fewer entries into the exposed open arms, and exhibit longer freezing durations, reflecting their reluctance to explore potentially dangerous areas.
Findings: Early DEHP Exposure Induces Anxiety
The results of the behavioral assessments provided clear evidence of the detrimental impact of early DEHP exposure. Male rats that had been exposed to DEHP during their prenatal and early postnatal development exhibited significantly increased anxiety-related behaviors in adulthood compared to control animals that received no DEHP.
Specifically, these DEHP-exposed rats demonstrated:
- Reduced Exploration of Open Arms: They spent considerably less time venturing into the open arms of the elevated plus maze.
- Preference for Enclosed Spaces: Conversely, they spent more time seeking refuge in the closed arms, indicative of a heightened sense of vulnerability in exposed areas.
- Increased Freezing Behavior: The duration of immobility (freezing) was significantly longer in the DEHP-exposed group, suggesting heightened fear and stress responses.
These findings strongly suggest that early-life exposure to DEHP can induce a persistent state of anxiety that manifests even in adulthood, in the absence of any ongoing exposure. This highlights the critical vulnerability of the developing brain to environmental insults.
Reversal of Effects: The Role of GABA and Testosterone
A crucial aspect of the study involved investigating whether the observed anxiety could be ameliorated by interventions targeting GABA and testosterone pathways. The researchers administered GABA agonists or testosterone to subsets of the adult male rats prior to the EPM test.
The results of these interventions were striking:
- GABA Agonist Treatment: Male rats exposed to DEHP that subsequently received GABA agonists showed a marked reduction in anxiety-related behaviors. Their exploration of the open arms increased, their preference for closed arms diminished, and their freezing time decreased, bringing their behavior closer to that of control animals.
- Testosterone Treatment: Similarly, DEHP-exposed rats treated with testosterone exhibited a reversal of the anxiety phenotype. They displayed increased exploration of the open arms and reduced freezing, indicating a counteraction of the anxiogenic effects of early DEHP exposure.
Dr. Ponzo commented on these pivotal findings: "This work demonstrates that contact with DEHP in the early stages of life could modify behavior with regard to anxiety, even in the absence of DEHP exposure in adulthood. These neuroendocrine changes can be reversed by treating with GABA agonists or testosterone."
These results underscore the interconnectedness of the endocrine and nervous systems in shaping behavior and suggest that DEHP’s impact on anxiety may be mediated through its disruption of the delicate balance of neurochemical signaling, particularly within the GABAergic system and potentially through alterations in androgen signaling.
Broader Implications and Expert Commentary
The implications of this research extend beyond the laboratory setting, raising significant public health concerns. The widespread presence of DEHP in consumer products means that populations, particularly developing fetuses and infants, are routinely exposed to this chemical. The study’s findings, while conducted in rodents, provide compelling evidence for potential long-lasting behavioral consequences in humans exposed during critical developmental periods.
Dr. Ponzo’s statement, emphasizing the lasting effects of early exposure and the potential for reversal, provides a crucial insight into the mechanisms at play. The fact that interventions targeting GABA and testosterone could reverse the anxiety phenotype suggests that DEHP might interfere with the proper development and function of neural circuits responsible for regulating mood and stress responses. This could involve alterations in the number or sensitivity of GABA receptors, or changes in the production or metabolism of testosterone and its effects on the brain.
While the study focused on male rats, it is important to note that endocrine-disrupting chemicals can have differential effects on males and females, and further research would be needed to ascertain the impact on female offspring and the specific mechanisms involved in their response.
Context of the Endocrine Society Annual Meeting
ENDO 2026, the annual meeting of the Endocrine Society, serves as a vital platform for the dissemination of cutting-edge research in endocrinology and related fields. The presentation of these findings at such a prestigious scientific gathering highlights the significance and potential impact of the research within the scientific community. The Endocrine Society itself is a global leader in promoting research, education, and advocacy for hormone health, and its annual meetings bring together thousands of researchers, clinicians, and policymakers to discuss critical issues in the field. The inclusion of this study in the ENDO 2026 program signals its relevance to ongoing discussions about the impact of environmental factors on human health.
Future Directions and Public Health Considerations
This research opens several avenues for future investigation. Further studies could explore:
- Dose-Response Relationships: Determining the specific doses of DEHP that elicit these effects and identifying sensitive windows of exposure.
- Mechanistic Detail: Delving deeper into the precise molecular mechanisms by which DEHP disrupts GABAergic and androgenic pathways during development.
- Long-Term Behavioral Outcomes: Investigating if other behavioral or cognitive deficits emerge over the lifespan of the exposed animals.
- Human Relevance: Designing epidemiological studies to investigate potential correlations between early-life DEHP exposure and anxiety disorders in human populations.
- Environmental Interventions: Exploring strategies to reduce human exposure to DEHP and other phthalates, particularly for vulnerable populations.
The findings serve as a stark reminder of the potential consequences of widespread chemical exposure during critical developmental periods. As regulatory bodies and public health organizations continue to assess the risks associated with EDCs, research like this provides essential scientific evidence to inform policy decisions aimed at protecting public health, especially the neurodevelopmental well-being of future generations. The ability to reverse some of these effects with targeted interventions also offers hope for developing therapeutic strategies for individuals affected by such exposures.
